Zenotech Laboratories Ltd Financials

Zenotech Laboratories Ltd Financial Statement

Zenotech Laboratories Ltd Income Statement

Quarterly

Annual

*All values are in Rs. Cr

Particulars	Sep 2024	Jun 2024	Mar 2024
Revenue	11.46	10.25	9.43
Operating Expense	7.36	6.48	6.33
Net Profit	1.35	1.29	0.66
Net Profit Margin	11.78	12.59	7.00
Earning Per Share	0.22	0.21	0.11
EBIDTA	3.10	3.02	2.39
Effective Tax Rate	TBA	TBA	TBA

Particulars	Sep 2024
Revenue	11.46
Operating Expense	7.36
Net Profit	1.35
Net Profit Margin	11.78
Earning Per Share	0.22
EBIDTA	3.10
Effective Tax Rate	TBA

Zenotech Laboratories Ltd Profit & Loss

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2024	Mar 2023	Mar 2022
Total Revenue Annual	40.83	42.42	36.57
Operating Expenses Annual	23.61	21.72	19.10
Operating Profit Annual	18.23	21.79	18.09
Interest Annual	TBA	0.11	1.22
Depreciation	7.09	7.17	6.97
Net Profit Annual	8.30	11.59	22.18
Tax Annual	2.84	2.92	-12.27

Particulars	Mar 2024
Total Revenue Annual	40.83
Operating Expenses Annual	23.61
Operating Profit Annual	18.23
Interest Annual	TBA
Depreciation	7.09
Net Profit Annual	8.30
Tax Annual	2.84

Zenotech Laboratories Ltd Cash Flow

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2024	Mar 2023	Mar 2022
Cash Flow at the Beginning	11.14	2.41	2.46
Cash Flow from Operations	11.82	20.66	17.67
Cash Flow from Investing	-21.15	-5.82	-1.84
Cash Flow from Financing	TBA	-6.11	-15.87
Cash Flow at the End	1.82	11.14	2.41

Particulars	Mar 2024
Cash Flow at the Beginning	11.14
Cash Flow from Operations	11.82
Cash Flow from Investing	-21.15
Cash Flow from Financing	TBA
Cash Flow at the End	1.82

Zenotech Laboratories Ltd Key Ratios

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2024	Mar 2023	Mar 2022
PBDIT Margin (%)	44.65	51.37	49.47
PBIT Margin (%)	27.28	34.46	30.41
PBT Margin (%)	27.28	-278.86	5.47
Net PROFIT Margin (%)	20.33	27.32	60.65
Return On Networth / Equity (%)	3.07	4.28	13.91
Return On Networth /Employed (%)	4.09	5.31	6.37
Return On Assets (%)	9.35	14.21	29.72
Total Debt / Equity (X)	TBA	0.04	0.22
Asset Turnover Ratio (%)	0.46	0.52	0.49

Particulars	Mar 2024
PBDIT Margin (%)	44.65
PBIT Margin (%)	27.28
PBT Margin (%)	27.28
Net PROFIT Margin (%)	20.33
Return On Networth / Equity (%)	3.07
Return On Networth /Employed (%)	4.09
Return On Assets (%)	9.35
Total Debt / Equity (X)	TBA
Asset Turnover Ratio (%)	0.46

Zenotech Laboratories Ltd Balance Sheet

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2024	Mar 2023	Mar 2022
Fixed Assets Annual	65.58	65.38	70.91
Total Current Assets Annual	26.16	16.26	7.37
Non Current Assets Annual	80.04	84.61	86.71
Total Shareholders Funds Annual	90.54	82.27	70.64
Total Assets Annual	106.21	100.87	94.08

Particulars	Mar 2024
Fixed Assets Annual	65.58
Total Current Assets Annual	26.16
Non Current Assets Annual	80.04
Total Shareholders Funds Annual	90.54
Total Assets Annual	106.21

Zenotech Laboratories Ltd Earning Calls

No Data Availabe

Dividend Pages

PE Ratio

Get Your FAQs Right

As of Dec 22, 2024, Zenotech Laboratories Ltd has a market capitalization of 360.75 Cr. Value Research classifies it as a Small-Cap company.

Yes, Zenotech Laboratories Ltd is debt-free with a debt-to-equity ratio of 0.00.

In FY 2023 , Zenotech Laboratories Ltd recorded a total revenue of approximately 36.76 Cr marking a significant milestone in the company's financial performance.

Zenotech Laboratories Ltd's Future outlook anticipates robust growth, with forecasted earnings and revenue rising approximately 0.1% and 0.1% annually, respectively..

Zenotech Laboratories Ltd's current PE ratio is 43.46.

Zenotech Laboratories Ltd's ROCE averaged 14.7% from the FY ending March 2022 to 2024, with a median of 14.3%. It peaked at 17.6% in March 2023, reflecting strong capital efficiency over the period..

Zenotech Laboratories Ltd's latest EBIT is Rs. 11.14 Cr, surpassing the average EBIT of Rs. 12.29 Cr over the 5 years..